Chronic fatigue syndrome versus sudden onset myalgic encephalomyelitis.
Jason, Leonard A, Evans, Meredyth, Brown, Abigail et al. · Journal of prevention & intervention in the community · 2015 · DOI
Quick Summary
This study looked at whether using a specific definition of ME (sudden onset myalgic encephalomyelitis) identifies a sicker group of patients compared to the broader CFS (chronic fatigue syndrome) definition. Researchers found that people who met the ME criteria had more severe symptoms, greater disability, and worse post-exertional malaise (feeling much worse after physical activity) than those meeting only the CFS criteria. The findings suggest that the ME definition may identify patients with more serious illness.
Why It Matters
This research helps clarify that ME and CFS may identify distinct patient populations with different severity profiles. For patients, this distinction could lead to more targeted treatment approaches and appropriate prognostication. For researchers, this suggests that case definitions significantly influence study populations and may explain variability in research outcomes across ME/CFS studies.
Observed Findings
Patients meeting ME criteria showed greater functional disabilities than those meeting only CFS criteria
Patients meeting ME criteria reported more severe post-exertional malaise symptoms
The revised sudden-onset ME definition identified a subgroup with more severe physical symptoms
The revised ME definition identified a subgroup with more severe mental and cognitive symptoms
Findings were consistent across two independent datasets with different recruitment methods
Inferred Conclusions
The revised sudden-onset ME case definition identifies a more severely affected patient population than the broader 1994 CFS definition
Post-exertional malaise severity may be a key distinguishing feature between ME and CFS populations
Case definition selection significantly impacts the characteristics of research and clinical populations identified
Remaining Questions
Do patients meeting ME criteria have different underlying biological abnormalities compared to CFS-only patients?
Are the differences in severity stable over time, or do CFS patients progress to meet ME criteria?
What This Study Does Not Prove
This study does not prove that ME and CFS are biologically distinct diseases—it only shows that different case definitions identify groups with different symptom severity. The cross-sectional design cannot establish whether the ME criteria are more accurate, more predictive of outcomes, or better reflect underlying pathology. It also does not determine what causes the observed differences in severity between the groups.